SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-15-006315
Filing Date
2015-11-13
Accepted
2015-11-13 12:34:37
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gff10q_111615p.htm 10-Q 265219
2 EXHIBIT 31.1 exh_311.htm EX-31.1 4958
3 EXHIBIT 31.2 exh_312.htm EX-31.2 5111
4 EXHIBIT 32.1 exh_321.htm EX-32.1 4292
  Complete submission text file 0001171843-15-006315.txt   1769289

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE xbit-20150930.xml EX-101.INS 231341
6 XBRL SCHEMA FILE xbit-20150930.xsd EX-101.SCH 22121
7 XBRL CALCULATION FILE xbit-20150930_cal.xml EX-101.CAL 20547
8 XBRL DEFINITION FILE xbit-20150930_def.xml EX-101.DEF 164362
9 XBRL LABEL FILE xbit-20150930_lab.xml EX-101.LAB 152517
10 XBRL PRESENTATION FILE xbit-20150930_pre.xml EX-101.PRE 176812
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37347 | Film No.: 151228011
SIC: 2834 Pharmaceutical Preparations